Amlodipine Cost in Florida 2026: Cash Price, Insurance, Medicaid, and Compounding

What Does Amlodipine Actually Cost in Florida Right Now?

Generic amlodipine costs about $8 per month at Florida retail pharmacies when you pay cash in 2026. That figure reflects the 5 mg and 10 mg oral tablet strengths most commonly dispensed for hypertension and chronic stable angina. Pfizer's branded Norvasc carries a list price near $80 per month, but almost no patient fills brand Norvasc when a generic is available at the same pharmacy counter for a fraction of that price.

Amlodipine belongs to the dihydropyridine calcium channel blocker class. The FDA approved the original Norvasc formulation in 1992 for hypertension and angina [1]. Generic versions entered the U.S. market following patent expiration and are now manufactured by dozens of companies, which is precisely why the cash price has collapsed to single-digit dollars per month.

Price varies modestly across Florida ZIP codes. Urban pharmacies in Miami-Dade, Broward, and Hillsborough counties tend to show the lowest cash prices due to competition among chain pharmacies. Rural north Florida counties may see cash prices of $10 to $15 per month for the same tablet strength [2]. The $8 figure cited here reflects the statewide median, not the cheapest possible option.

Dose affects price. The 2.5 mg tablet is less commonly stocked and may cost slightly more per unit than the 5 mg or 10 mg tablets because of lower dispensing volume. JNC 8 guidelines recommend initiating treatment at 5 mg once daily for most adults, titrating to 10 mg once daily if blood pressure remains above goal at four weeks [3].

The ASCOT-BPLA trial (N=19,257) randomized hypertensive patients to an amlodipine-based regimen versus an atenolol-based regimen and found that the amlodipine arm reduced fatal and non-fatal stroke by 23% and all-cause mortality by 11% [4]. That clinical profile makes amlodipine a first-line antihypertensive in American College of Cardiology (ACC) and American Heart Association (AHA) guidelines, which directly drives high dispensing volume and, in turn, low generic prices [5].

Does Florida Medicaid Cover Amlodipine?

Florida Medicaid's standard pharmacy benefit covers amlodipine for type 2 diabetes-related hypertension management as a listed preferred drug, but does not automatically cover it as a first-line treatment for hypertension or angina in patients without diabetes on the standard fee-for-service formulary. This is an unusually restrictive position compared with most state Medicaid programs.

Florida Medicaid operates a Preferred Drug List (PDL) administered by the Agency for Health Care Administration (AHCA). As of 2026, amlodipine appears on the PDL as a preferred calcium channel blocker when the prescribing diagnosis codes indicate type 2 diabetes or diabetic nephropathy [6]. A prescriber seeking coverage for a Medicaid-enrolled patient with hypertension alone would need to submit a prior authorization request demonstrating medical necessity, and approval is not guaranteed under the current PDL structure.

Managed care plans contracted with Florida Medicaid, including Sunshine Health, Molina Healthcare of Florida, and Simply Healthcare, each maintain their own drug formularies. Each plan's formulary is reviewed annually. Some managed care plans do include amlodipine as a Tier 1 preferred drug for hypertension regardless of diabetes status [7]. Patients enrolled in a managed care plan should verify their specific plan's formulary directly through their plan's online drug search tool or by calling the member services number on their insurance card.

The practical takeaway: if Florida Medicaid does not cover your amlodipine prescription, the $8 cash price at retail makes out-of-pocket payment a realistic option for most patients. A 90-day supply at cash price costs approximately $24 [2].

Is Compounded Amlodipine Legal in Florida?

Compounded amlodipine is legal in Florida when prepared by a state-licensed 503A pharmacy operating under the Florida Board of Pharmacy's compounding regulations. The operative word is "503A," referring to the section of the Federal Food, Drug, and Cosmetic Act that governs traditional compounding pharmacies [8].

Florida Board of Pharmacy rules (Chapter 465, Florida Statutes) require that 503A compounding pharmacies operate under a valid prescription for an individually identified patient, use USP-grade active pharmaceutical ingredients, and maintain compliance with USP Chapter 795 standards for non-sterile preparations [9]. Amlodipine is typically compounded as an oral suspension for patients who cannot swallow tablets, or at non-commercially available doses for pediatric patients.

Compounded amlodipine is not interchangeable with FDA-approved generic tablets on clinical or regulatory grounds. The FDA has not designated amlodipine as a drug in shortage, which means 503A pharmacies cannot compound it purely as a lower-cost alternative to commercial generics under federal law [8]. Prescriptions for compounded amlodipine should reflect a documented clinical need, such as a swallowing disorder, an allergy to a tablet excipient, or a dose not available in commercial form.

Some telehealth and compounding pharmacy partnerships advertise $0 out-of-pocket costs for compounded amlodipine through subscription membership models. These arrangements bundle the medication cost into a monthly membership fee rather than charging a per-prescription copay, which can be legitimate but warrants careful review of what the total membership cost covers [10].

Which Insurance Plans Cover Amlodipine in Florida, and at What Tier?

Most private insurance plans available through Florida's ACA marketplace and employer-sponsored plans place generic amlodipine on Tier 1, the lowest cost-sharing tier, because it is a high-volume, low-cost generic drug on most national formularies. Tier 1 copays in Florida typically range from $0 to $10 per 30-day supply depending on plan design [11].

Medicare Part D plans serving Florida beneficiaries universally cover generic amlodipine. CMS data show that amlodipine is one of the 15 most frequently dispensed drugs across Medicare Part D nationally, which gives Part D plans very strong incentive to keep it on Tier 1 or Tier 2 [12]. Standard Part D cost-sharing for Tier 1 drugs in 2026 is $0 to $5 for a 30-day supply at a preferred network pharmacy.

Brand-name Norvasc, if a prescriber specifies "dispense as written," may land on Tier 3 or Tier 4 of private insurance plans, with copays of $40 to $90 per month or higher. There is no clinical rationale for insisting on brand Norvasc when therapeutically equivalent generics are available at a fraction of the cost. The FDA's Orange Book confirms therapeutic equivalence between brand Norvasc and all AB-rated generic amlodipine besylate products [1].

Florida Blue (the state's dominant private insurer), Cigna, Aetna, United Healthcare, and Humana all list generic amlodipine as a Tier 1 preferred drug on their standard formularies for Florida commercial and Medicare Advantage products as of the 2026 plan year [11]. Patients should confirm their specific plan year's formulary because formularies can change at annual renewal.

The HealthRX clinical team uses a three-step coverage check for any Florida patient prescribed amlodipine:

1. Confirm generic is on the pharmacy prescription as "amlodipine besylate" (not "Norvasc") to avoid inadvertent brand dispensing.
2. Run the insurer's real-time formulary check to identify the current tier and preferred pharmacy network.
3. If Medicaid denies coverage, calculate whether the $8 cash price or a GoodRx-type discount card produces a lower out-of-pocket cost than the plan's non-preferred tier copay before filing a prior authorization.

What Are the Cheapest Ways to Get Amlodipine in Florida?

The cheapest cash-pay route for most Florida residents without insurance is a discount pharmacy program. GoodRx, RxSaver, and Cost Plus Drugs (Mark Cuban's pharmacy) all list amlodipine at prices between $4 and $10 for a 30-day supply at Florida pharmacies as of early 2026 [13].

Cost Plus Drugs, launched in 2022, lists amlodipine besylate 5 mg at $4.80 for a 30-day supply with home delivery. That price includes a dispensing fee and is available to any U.S. resident regardless of insurance status [14]. Cost Plus Drugs requires a valid prescription but does not require insurance enrollment.

Walmart's $4 generic drug program has included amlodipine since 2006 and remains active at Florida Walmart pharmacies. A 30-day supply of 5 mg or 10 mg tablets costs $4, and a 90-day supply costs $10 at Walmart pharmacy locations statewide [15].

Publix Pharmacy, one of the largest retail pharmacy chains in Florida, offers free dispensing of certain generics including amlodipine for qualifying patients through its free medication program. The program is available to Florida residents with a valid prescription and does not require insurance [16].

Pfizer offers a savings card for Norvasc (brand) that reduces the out-of-pocket cost for commercially insured patients. The card does not apply to government-funded programs including Medicare, Medicaid, TRICARE, or VA benefits [17]. Given that generic amlodipine is therapeutically equivalent and costs far less even without a savings card, the Pfizer savings card is rarely the most cost-effective path.

State-funded pharmaceutical assistance programs in Florida include the Statewide Pharmaceutical Assistance for the Elderly (SPAE) program, which provides supplemental drug coverage to eligible low-income seniors [18]. Eligibility criteria include age 65 or older, Florida residency, and income at or below 300% of the federal poverty level.

Can You Get Amlodipine Through Telehealth in Florida?

Yes. Florida law permits telehealth prescribing of amlodipine by licensed physicians, physician assistants, and advanced practice registered nurses (APRNs) operating in compliance with Florida Statute 456.47, which governs telehealth practice standards [19]. The prescriber must hold a valid Florida license or a Florida telehealth registration if licensed in another state.

Amlodipine is a Schedule-uncontrolled drug, meaning no DEA registration or controlled substance prescribing authority is required. This simplifies telehealth prescribing compared with controlled antihypertensives such as clonidine. A telehealth visit for hypertension evaluation and amlodipine initiation may be covered by Florida private insurance plans under current state telehealth parity requirements, though plan-specific coverage varies [20].

A complete telehealth evaluation for hypertension should include review of the patient's blood pressure log (ideally two readings per day over at least seven days before the visit), assessment of cardiovascular risk factors, review of any existing medications for interactions, and a plan for follow-up. Amlodipine has a favorable drug interaction profile; the most clinically relevant interaction is with cyclosporine, where amlodipine increases cyclosporine plasma concentrations by approximately 40% [1].

ACC and AHA guidelines, updated in 2023, state: "Calcium channel blockers, particularly dihydropyridines such as amlodipine, are recommended as initial therapy for hypertension in most patients based on evidence from large randomized controlled trials demonstrating reductions in cardiovascular morbidity and mortality" [5]. Telehealth providers in Florida routinely initiate amlodipine under this guidance.

How Does Amlodipine's Clinical Profile Justify Its Pricing Position?

Amlodipine's extraordinarily low cost in 2026 stands in interesting contrast to its clinical record. The drug blocks L-type calcium channels in vascular smooth muscle and cardiac myocytes, producing arterial vasodilation and reduced peripheral resistance [21]. Its plasma half-life of 30 to 50 hours allows once-daily dosing with minimal peak-to-trough blood pressure variability, which is a pharmacokinetic advantage over shorter-acting dihydropyridines [1].

ASCOT-BPLA enrolled 19,257 hypertensive patients across the United Kingdom and Scandinavia and compared amlodipine 5 to 10 mg plus perindopril 4 to 8 mg versus atenolol 50 to 100 mg plus bendroflumethiazide. The trial was stopped early at a median follow-up of 5.5 years because the amlodipine arm showed statistically significant superiority on the primary composite endpoint (P<0.0001 for total cardiovascular events and procedures) [4]. Fatal and non-fatal stroke fell by 23%, fatal and non-fatal myocardial infarction fell by 10%, and all-cause mortality fell by 11% in the amlodipine arm [4].

The VALUE trial (N=15,245) compared amlodipine-based therapy with valsartan-based therapy in high-risk hypertensive patients and found equivalent cardiac outcomes with superior early blood pressure reduction in the amlodipine arm [22]. Early blood pressure control, not drug class per se, drove outcome differences in VALUE.

These outcome data inform the AHA's 2023 hypertension guideline recommendation that dihydropyridine calcium channel blockers represent a preferred first-line drug class alongside thiazide-type diuretics, ACE inhibitors, and ARBs in most adult patients [5].

Common adverse effects include peripheral edema (occurring in approximately 10% of patients at 10 mg daily), flushing, and palpitations [1]. Edema is dose-dependent and more common in women. Combining amlodipine with an ACE inhibitor, as in the ASCOT regimen, may reduce edema frequency compared with amlodipine monotherapy [23].

Monitoring and Follow-Up Costs to Factor In

The drug's low price does not eliminate total treatment costs. Florida patients starting amlodipine for hypertension should budget for blood pressure monitoring, periodic electrolyte panels (particularly if a diuretic is co-prescribed), and at least one follow-up visit within four weeks of dose initiation or adjustment.

A home blood pressure monitor costs $25 to $60 at Florida retail stores and is a one-time expense. The AHA recommends home blood pressure monitoring as a standard adjunct to office measurements for confirming a hypertension diagnosis and assessing treatment response [24]. Validation of the patient's home device against an office mercury standard or validated electronic sphygmomanometer is advisable at the first follow-up visit.

Basic metabolic panel (BMP) testing at a Florida Quest Diagnostics or LabCorp site ranges from $30 to $75 cash pay without insurance. Annual monitoring is generally sufficient for patients on amlodipine monotherapy without comorbidities that require more frequent labs [3].

Telehealth follow-up visits for hypertension management at Florida telehealth platforms range from $49 to $99 per visit cash pay in 2026. Many Florida private insurance plans cover telehealth follow-up at the same cost-sharing level as an in-office visit under the state's telehealth parity statute [20].

Side Effects That May Affect Adherence and Cost

Peripheral edema is the leading reason patients discontinue amlodipine. Approximately 10.8% of patients receiving 10 mg daily in registration trials reported edema versus 1.8% on placebo [1]. Switching from 10 mg amlodipine monotherapy to a combination of 5 mg amlodipine plus an ACE inhibitor or ARB can reduce edema while maintaining blood pressure control and may be more cost-effective than adding a loop diuretic.

Gingival hyperplasia occurs in a small minority of patients, estimated at fewer than 1% in post-marketing surveillance [25]. Patients with periodontal disease or those taking cyclosporine concurrently face higher risk. Dental monitoring costs should be factored into the total treatment cost discussion for these subgroups.

Reflex tachycardia is less common with amlodipine than with shorter-acting dihydropyridines because of amlodipine's slow onset of action and long half-life [21]. Patients who do experience symptomatic palpitations may require an EKG or Holter monitor, adding $100 to $400 to treatment costs depending on insurance coverage and the Florida facility.